Richard Delorme

Head
Center of Excellence for Autism Spectrum Disorders and Neurodevelopmental Disorders

Richard Delorme is head of the Center of Excellence for Autism Spectrum Disorders and Neurodevelopmental Disorders (InovAND) and head of the Department of Child and Adolescent Psychiatry at the Robert Debré Hospital, both in Paris, France. He has a broad background in child psychiatry and genetics, with expertise in the identification of biomarkers in rare diseases associated with autism. He is also a researcher at the Human Genetics and Cognitive Functions Laboratory at the Institut Pasteur, in Paris. In recent years, he has been involved in several research programs, brain imaging studies and IPSC-based drug screening technology. He is an author on more than 100 publications.

From this contributor

Explore more from The Transmitter

Why emotion research is stuck—and how to move it forward

Studying how organisms infer indirect threats and understand changing contexts can establish a common framework that bridges species and levels of analysis.

By Joshua P. Johansen
26 January 2026 | 0 min watch

After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process

A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.

By Angie Voyles Askham
23 January 2026 | 3 min read
Curvy lines link brain scans and a world map.

BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding

But whether the initiative’s road map for the next decade is feasible remains an open question.

By Claudia López Lloreda
23 January 2026 | 6 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.